ABCG2 and cancer: To investigate if PZ-39 can reverse ABCG2-mediated multidrug resistance in a drug resistant cancer cell line, we used the drug-selected MCF7/AdVp3000 cells and tested two additional anticancer drug substrates of ABCG2, Adriamycin and camptothecin.